Showing results (2631-2640 of 2,757) with videos related to
Sort By:
Pageof 276
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2021
Biomarkers of Inflammation and Oxidative Stress among Adult Former Smoker, Current E-Cigarette Users-Results from Wave 1 PATH StudyCarol H Christensen, Joanne T Chang, Brian L Rostron, et al.Cell|April 19, 2020
Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal AdenocarcinomaKatherine Minjee Chung, Jaffarguriqbal Singh, Lauren Lawres, et al.Genome Biology|November 2, 2019
Optimizing sequencing protocols for leaderboard metagenomics by combining long and short readsJon G Sanders, Sergey Nurk, Rodolfo A Salido, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 2, 2020
Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic CancerSara A Väyrynen, Jinming Zhang, Chen Yuan, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 9, 2019
Guidelines Insights: Hepatobiliary Cancers, Version 2.2019Al B Benson, Michael I D'Angelica, Daniel E Abbott, et al.Therapeutic Advances in Medical Oncology|August 7, 2023
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimensHui Chen, Qingqing Ding, Laila Khazai, et al.Breast Cancer Research : BCR|May 7, 2026
The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancerSahil Seth, Clinton Yam, Lei Huo, et al.The Journal of Clinical Investigation|June 3, 2025
FGFR3-induced Y158 PARP1 phosphorylation promotes PARP inhibitor resistance via BRG1/MRE11-mediated DNA repair in breast cancer modelsMei-Kuang Chen, Hirohito Yamaguchi, Yuan Gao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast CancerClinton Yam, Er-Yen Yen, Jeffrey T Chang, et al.JHEP Reports : Innovation in Hepatology|February 2, 2026
Practice changing RCT design and rationale: Abbreviated MRI plus AFP vs. ultrasound plus AFP for HCC surveillance in cirrhosis (PREMIUM study)George N Ioannou, Tamar H Taddei, Beata M Planeta, et al.Pageof 276